BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28302097)

  • 1. Objective response to mTOR inhibition in a metastatic collision tumor of the liver composed of melanoma and adenocarcinoma with TSC1 loss: a case report.
    Bhangoo MS; Zhou JY; Ali SM; Madison R; Schrock AB; Costantini C
    BMC Cancer; 2017 Mar; 17(1):197. PubMed ID: 28302097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
    Lim SM; Park HS; Kim S; Kim S; Ali SM; Greenbowe JR; Yang IS; Kwon NJ; Lee JL; Ryu MH; Ahn JH; Lee J; Lee MG; Kim HS; Kim H; Kim HR; Moon YW; Chung HC; Kim JH; Kang YK; Cho BC
    Oncotarget; 2016 Mar; 7(9):10547-56. PubMed ID: 26859683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
    Ding L; Han L; Li Y; Zhao J; He P; Zhang W
    Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of TSC1 mutation spectrum in mucosal melanoma.
    Ma M; Dai J; Xu T; Yu S; Yu H; Tang H; Yan J; Wu X; Yu J; Chi Z; Si L; Cui C; Sheng X; Kong Y; Guo J
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):257-267. PubMed ID: 29185092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma.
    Voelter V; Diserens AC; Moulin A; Nagel G; Yan P; Migliavacca E; Rimoldi D; Hamou MF; Kaina B; Leyvraz S; Hegi ME
    Int J Cancer; 2008 Sep; 123(5):1215-8. PubMed ID: 18546261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary collision neoplasm of malignant melanoma and adenocarcinoma in the lung. A case report.
    Ueyama T; Tsuru T; Tsuneyoshi M; Sueishi K; Sibuya T; Fukuda T
    Pathol Res Pract; 1993 Mar; 189(2):178-83. PubMed ID: 8321746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?
    Santini D; Vincenzi B; Venditti O; Dell'Aquila E; Frezza AM; Silletta M; Guida FM; Grasso RF; Silvestris N; Lanzetta G; Tonini G
    Future Oncol; 2013 Dec; 9(12):1809-11. PubMed ID: 24295410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
    Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
    Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
    Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer.
    Waqar SN; Baggstrom MQ; Morgensztern D; Williams K; Rigden C; Govindan R
    Chemotherapy; 2016; 61(3):144-7. PubMed ID: 26780363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collision tumor of thyroid: metastatic lung adenocarcinoma plus papillary thyroid carcinoma.
    Nabili V; Natarajan S; Hirschovitz S; Bhuta S; Abemayor E
    Am J Otolaryngol; 2007; 28(3):218-20. PubMed ID: 17499145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report.
    Casadevall D; Vidal J; Gallardo F; Zuccarino F; Arumí-Uría M; Dalmases A; Bellosillo B; Montagut C
    J Med Case Rep; 2016 Jun; 10(1):158. PubMed ID: 27255157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate in the treatment of metastatic uveal melanoma--first experiences.
    Berger TG; Dieckmann D; Efferth T; Schultz ES; Funk JO; Baur A; Schuler G
    Oncol Rep; 2005 Dec; 14(6):1599-603. PubMed ID: 16273263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collision of Malignant Melanoma and Squamous Cell Carcinoma in Rectum: First Report of a Rare Tumor.
    Siraj F; Shruti S; Jain S; Bhatnagar A; Agrawal U
    Turk Patoloji Derg; 2019; 35(3):237-241. PubMed ID: 28832076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma.
    Karg MM; John L; Refaian N; Buettner C; Rottmar T; Sommer J; Bock B; Resheq YJ; Ksander BR; Heindl LM; Mackensen A; Bosch JJ
    Mol Cancer Res; 2022 Aug; 20(8):1320-1336. PubMed ID: 35503453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
    Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal Melanoma Metastatic to the Liver: Chemoembolization With 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea.
    Gonsalves CF; Eschelman DJ; Thornburg B; Frangos A; Sato T
    AJR Am J Roentgenol; 2015 Aug; 205(2):429-33. PubMed ID: 25905562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report].
    Muneoka K; Shirai Y; Yokoyama N; Wakai T; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):231-3. PubMed ID: 15751639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of liver metastases from uveal melanoma.
    Rivoire M; Kodjikian L; Baldo S; Kaemmerlen P; Négrier S; Grange JD
    Ann Surg Oncol; 2005 Jun; 12(6):422-8. PubMed ID: 15886904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.